Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy.
about
Pneumonia during remission induction chemotherapy in patients with acute leukemia.Prior cytopenia predicts worse clinical outcome in acute myeloid leukemia.Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group studyGenetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantationHematopoietic stem cell transplantation for MDS.Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemiaIdarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013).Efficacy and safety of homoharringtonine plus cytarabine and aclarubicin for patients with myelodysplastic syndrome-RAEB.Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classificationsTreatment of acute myeloid leukemia with 20-30% bone marrow blasts.Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.Discovering transcription and splicing networks in myelodysplastic syndromes.Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalities.Acute myeloid leukemia - strategies and challenges for targeting oncogenic Hedgehog/GLI signalingEpigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemiaRecent advances in the diagnosis and classification of myeloid neoplasms--comments on the 2008 WHO classification.Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia.
P2860
Q33410062-4A732723-FD98-4727-9F00-6BC268163F08Q33424807-9C4908E2-69A3-4C5B-B67D-70D463788D28Q33558709-222FC55D-63A0-470E-9F29-D9F3726FCA91Q33615619-46C4020A-E3B5-4CE4-AD27-27FF8A4BE1EEQ33767314-8D8ACD8F-F0A5-4758-8AB0-B139BF8AB9B0Q33840247-63457654-CECC-4789-8754-30D1B357BD5CQ35628954-B51EC1AE-8430-4618-8B9B-DEAFA84C2BF2Q36158816-2B28030F-61D9-4FFC-98DE-25E4E2B3C16EQ36503074-BFDE8D48-DD79-420A-B464-51222EC7687BQ36804633-2C6A7041-6D0F-4E5D-8112-B3E4BB4D610FQ36934199-9150AD5C-A6AF-4314-A14A-70DDA2DBEEF8Q37263146-5E4241B0-0232-4ADF-8EAA-4A33CBE19CABQ37309196-80C82318-407B-436E-9C5C-514BC27487E8Q37480178-A164A5B9-797E-4458-9C04-C69CE895B4EFQ37607838-CBCA2FF1-E955-4127-B18C-F721B1A0886DQ37635209-B9D42E97-1BC7-481C-91B9-E3EA173A31E5Q37772200-D72C06DA-7863-4BE3-960F-A531C3A34370Q42720213-52980C59-A7E5-45A4-8AB8-17B6683A3F71
P2860
Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy.
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Effect of diagnosis (refractor ...... come of AML-type chemotherapy.
@ast
Effect of diagnosis (refractor ...... come of AML-type chemotherapy.
@en
Effect of diagnosis (refractor ...... come of AML-type chemotherapy.
@nl
type
label
Effect of diagnosis (refractor ...... come of AML-type chemotherapy.
@ast
Effect of diagnosis (refractor ...... come of AML-type chemotherapy.
@en
Effect of diagnosis (refractor ...... come of AML-type chemotherapy.
@nl
prefLabel
Effect of diagnosis (refractor ...... come of AML-type chemotherapy.
@ast
Effect of diagnosis (refractor ...... come of AML-type chemotherapy.
@en
Effect of diagnosis (refractor ...... come of AML-type chemotherapy.
@nl
P2093
P1433
P1476
Effect of diagnosis (refractor ...... tcome of AML-type chemotherapy
@en
P2093
P304
P407
P577
1997-10-01T00:00:00Z